Cargando…

Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569589/ https://www.ncbi.nlm.nih.gov/pubmed/37841426 http://dx.doi.org/10.3389/fonc.2023.1294881

Ejemplares similares

AnnexinA5 Might Suppress the Phenotype of Human Gastric Cancer Cells via ERK Pathway
por: Wang, Xiaojie, et al.
Publicado: (2021)

AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis
por: Stöhr, R., et al.
Publicado: (2018)

AnnexinA6: a potential therapeutic target gene for extracellular matrix mineralization
por: Yang, Jie, et al.
Publicado: (2023)

Ultrasensitive Diamond Microelectrode Application in the Detection of Ca(2+) Transport by AnnexinA5-Containing Nanostructured Liposomes
por: Pasquarelli, Alberto, et al.
Publicado: (2022)

Clumping factor A of Staphylococcus aureus interacts with AnnexinA2 on mammary epithelial cells
por: Ashraf, Shoaib, et al.
Publicado: (2017)

AnnexinA7 promotes epithelial–mesenchymal transition by interacting with Sorcin and contributes to aggressiveness in hepatocellular carcinoma
por: Ling, Fei, et al.
Publicado: (2021)

Association of pro-fibrinolytic receptor AnnexinA2 with tissue plasminogen activator/Inhibitor-1 in pre-eclampsia
por: Ruikar, Komal, et al.
Publicado: (2023)

The Metalloprotease, Mpr1, Engages AnnexinA2 to Promote the Transcytosis of Fungal Cells across the Blood-Brain Barrier
por: Na Pombejra, Sarisa, et al.
Publicado: (2017)

Fluid Shear Stress Regulates Osteogenic Differentiation via AnnexinA6-Mediated Autophagy in MC3T3-E1 Cells
por: Pei, Tong, et al.
Publicado: (2022)

High co-expression of the SDF1/CXCR4 axis in hepatocarcinoma cells is regulated by AnnexinA7 in vitro and in vivo
por: Wang, Jingwen, et al.
Publicado: (2018)

Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes
por: Purvis, Gareth S. D., et al.
Publicado: (2019)

Retraction: RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway
Publicado: (2020)

Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells via ERK/JNK Pathway
por: Cheng, Jianghong, et al.
Publicado: (2021)

Retraction: Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways
Publicado: (2021)

Annexin A5 regulates Leydig cell testosterone production via ERK1/2 pathway
por: He, Ze, et al.
Publicado: (2016)

PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway
por: Yan, Hongzhu, et al.
Publicado: (2020)

AB072. Annexin A5 regulates Leydig cell testosterone production via ERK1/2 pathway
por: He, Ze, et al.
Publicado: (2015)

AB080. Annexin A5 regulates Leydig cell testosterone production via ERK1/2 pathway
por: He, Ze, et al.
Publicado: (2017)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

Silencing of LncRNA C1RL-AS1 Suppresses the Malignant Phenotype in Gastric Cancer Cells via the AKT/β-Catenin/c-Myc Pathway
por: Zhen-Hua, Wu, et al.
Publicado: (2020)

RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway
por: Su, Jian, et al.
Publicado: (2019)

EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways
por: Pan, Hongda, et al.
Publicado: (2019)

Suppressing ERK Pathway Impairs Glycochenodeoxycholate-Mediated Survival and Drug-Resistance in Hepatocellular Carcinoma Cells
por: Li, Bingxin, et al.
Publicado: (2021)

Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways
por: Sun, Xujuan, et al.
Publicado: (2018)

Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways
por: Pan, Hongda, et al.
Publicado: (2021)

SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation
por: Song, Yunda, et al.
Publicado: (2020)

Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways
por: Gupta, Ishita, et al.
Publicado: (2021)

5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells
por: Zhang, Xuehua, et al.
Publicado: (2023)

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
por: Wang, Xiaomeng, et al.
Publicado: (2019)

Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling
por: Cheng, Lanming, et al.
Publicado: (2020)

Puerarin Suppress Apoptosis of Human Osteoblasts via ERK Signaling Pathway
por: Liu, Ling-juan, et al.
Publicado: (2013)

Silencing PRSS1 suppresses the growth and proliferation of gastric carcinoma cells via the ERK pathway
por: Ye, Dongmei, et al.
Publicado: (2021)

Transcriptional Regulation of ING5 and its Suppressive Effects on Gastric Cancer
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

Exosome Released FZD10 Increases Ki-67 Expression via Phospho-ERK1/2 in Colorectal and Gastric Cancer
por: Scavo, Maria Principia, et al.
Publicado: (2021)

BAG2 Promotes Proliferation and Metastasis of Gastric Cancer via ERK1/2 Signaling and Partially Regulated by miR186
por: Sun, Lisha, et al.
Publicado: (2020)

Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia
por: Zhang, Nan, et al.
Publicado: (2020)

Expression of annexin A2 in adenomyosis and dysmenorrhea
por: Liu, Feng, et al.
Publicado: (2019)

Retraction: Hyperthermia-Induced NDRG2 Upregulation Inhibits the Invasion of Human Hepatocellular Carcinoma via Suppressing ERK1/2 Signaling Pathway
Publicado: (2020)

Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway
por: Shao, Shijie, et al.
Publicado: (2022)

Ononin Shows Anticancer Activity Against Laryngeal Cancer via the Inhibition of ERK/JNK/p38 Signaling Pathway
por: Ye, Ben, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_klu66f6459p8udtijvppe3nc2h